All Stories

  1. CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and biochemical outcomes from a three-month double-blind, placebo-controlled study
  2. Potential Predictors of Pain and Stiffness Response Following Genicular Artery Embolization for Knee Osteoarthritis
  3. CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and Biochemical Outcomes from a 3-Month Double-Blind, Placebo-Controlled Study
  4. Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19
  5. Genicular Artery Embolization for Treatment of Knee Osteoarthritis: Interim Analysis of a Prospective Pilot Trial Including Effect on Serum Osteoarthritis-Associated Biomarkers
  6. Pathological tissue formation and degradation biomarkers correlate with patient reported pain outcomes: an explorative study
  7. Genicular artery embolization for treatment of knee osteoarthritis pain: Systematic review and meta-analysis
  8. Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis
  9. Pathological Tissue Formation and Degradation Biomarkers Correlate with Patient Reported Outcomes
  10. 14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritis
  11. Periostin loss-of-function protects mice from post-traumatic and age-related osteoarthritis
  12. Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism
  13. The combination of an inflammatory peripheral blood gene expression and imaging biomarkers enhance prediction of radiographic progression in knee osteoarthritis
  14. The Combination of an Inflammatory Peripheral Blood Gene Expression and Imaging Biomarkers Enhance Prediction of Radiographic Progression in Knee Osteoarthritis.
  15. The Combination of an Inflammatory Peripheral Blood Gene Expression and Imaging Biomarkers Enhance Prediction of Radiographic Progression in Knee Osteoarthritis.
  16. Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration
  17. The Combination of an Inflammatory Peripheral Blood Transcriptome and Imaging Biomarkers Enhance Prediction of Radiographic Progression in Knee Osteoarthritis.
  18. Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease
  19. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation
  20. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort
  21. Translational control maintains cartilage homeostasis and regulates osteoarthritis progression
  22. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis
  23. Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study
  24. Toward understanding the role of cartilage particulates in synovial inflammation
  25. Serum Urate Levels Predict Joint Space Narrowing in Non‐Gout Patients With Medial Knee Osteoarthritis
  26. Increased Activity of the Chondrocyte Translational Apparatus Accompanies Osteoarthritic Changes in Human and Rodent Knee Cartilage
  27. 2016 Annual Meeting of the Orthopaedic Research Society Orlando, FL March 5-8, 2016
  28. Cytokine preconditioning of engineered cartilage provides protection against interleukin-1 insult
  29. Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis
  30. Low-Grade Inflammation in Symptomatic Knee Osteoarthritis: Prognostic Value of Inflammatory Plasma Lipids and Peripheral Blood Leukocyte Biomarkers
  31. Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
  32. Deletion of Panx3 Prevents the Development of Surgically Induced Osteoarthritis
  33. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13
  34. Human chondrocyte migration behaviour to guide the development of engineered cartilage
  35. Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
  36. Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients Are Responsive to Methotrexate, Anti-TNF, and T Cell Costimulatory Modulation
  37. F-Spondin Deficient Mice Have a High Bone Mass Phenotype
  38. TSG-6 activity as a novel biomarker of progression in knee osteoarthritis
  39. Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study
  40. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
  41. Prognostic biomarkers in osteoarthritis
  42. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis
  43. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA
  44. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription
  45. Perturbation of nuclear lamin A causes cell death in chondrocytes
  46. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis
  47. Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage
  48. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis
  49. Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis
  50. The role of microRNA in rheumatoid arthritis and other autoimmune diseases
  51. F-spondin regulates chondrocyte terminal differentiation and endochondral bone formation
  52. Protein Kinase C-  Mediates Negative Feedback on Regulatory T Cell Function
  53. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?
  54. Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations
  55. Erratum
  56. Developments in the scientific understanding of osteoarthritis
  57. F‐spondin, a neuroregulatory protein, is up‐regulated in osteoarthritis and regulates cartilage metabolism via TGF‐β activation
  58. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production
  59. Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage
  60. Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: Effects of statins and farnesyl and geranylgeranyl transferase inhibitors
  61. Classification of osteoarthritis biomarkers: a proposed approach
  62. Prospects for disease modification in osteoarthritis
  63. Gene Mining and Functional Genomics in Human Osteoarthritis